Username Password
About People & Picks | Help | Sign up
Home My P&P People Picks Tops Blogs Groups
S&P 500: 1,306.59 Change: -1.49%
AndrewGreenBull
AndrewGreenBull
P&P Score: 23.99   Points: -7.74   Accuracy: 37.50%   Average Pick Score: -4.85   Annual Return: 1.04% (2.61% since 11/18/09)  

AndrewGreenBull's Blog : DARA Set to Sky Rocket by Thursday

Date November 17, 2009    Comments Comments (0)    Recommended (83)   
Bookmark and Share
Abuse this post  Report Abuse
Please report this as abuse only if you believe it violates People And Picks  Terms of Use
You must log in to send an abuse report.
Share ThisShare This
Phase 2 clinical data of DARA’s leading drug candidate KRN5500 will be presented at 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain which will be held on 11/19-11/21(Thursday-Saturday), If positive data is released, DARA will break the ceiling without doubt.

Besides KRN5500 for Chronic neuropathic pain, DARA also has a therapy portfolio for type 2 diabetes which includes DB959, DB160 &DB900, and DB200 for psoriasis.

DARA has only 15M market cap, but KRN5500 alone is worth more than the entire market value.
It is obvious that the current stock price .46 is way under value.

There is a recent recommendation for DARA, check it out!

http://finance.yahoo.com/news/SmallCap-DARA-Bio-Worth-a-zacks-628902537.html?x=0&.v=1



Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.
Sponsored Links
©2008-2012 PeopleAndPicks.com | Terms of Use